Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO

WAO Pediatric Asthma Committee; Nikolaos G Papadopoulos; Adnan Custovic; Antoine Deschildre; Aziz Sheikh

doi:10.1111/pai.14129

Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO

WAO Pediatric Asthma Committee, Nikolaos G Papadopoulos^*, Adnan Custovic, Antoine Deschildre, Aziz Sheikh

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Abstract

Monitoring is a major component of asthma management in children. Regular monitoring allows for diagnosis confirmation, treatment optimization, and natural history review. Numerous factors that may affect disease activity and patient well-being need to be monitored: response and adherence to treatment, disease control, disease progression, comorbidities, quality of life, medication side-effects, allergen and irritant exposures, diet and more. However, the prioritization of such factors and the selection of relevant assessment tools is an unmet need. Furthermore, rapidly developing technologies promise new opportunities for closer, or even "real-time," monitoring between visits. Following an approach that included needs assessment, evidence appraisal, and Delphi consensus, the PeARL Think Tank, in collaboration with major international professional and patient organizations, has developed a set of 24 recommendations on pediatric asthma monitoring, to support healthcare professionals in decision-making and care pathway design.

Original language	English
Article number	e14129
Number of pages	15
Journal	Pediatric Allergy and Immunology
Volume	35
Issue number	4
DOIs	https://doi.org/10.1111/pai.14129
Publication status	Published - 25 Apr 2024

Keywords / Materials (for Non-textual outputs)

Humans
Asthma/diagnosis
Child
Quality of Life
Anti-Asthmatic Agents/therapeutic use
Delphi Technique
Monitoring, Physiologic/methods

Access to Document

10.1111/pai.14129Licence: Creative Commons: Attribution (CC-BY)

Recommendations for asthma monitoring_PAPADOPOULOS_DOA25032024_VOR_CC-BYFinal published version, 1.12 MBLicence: Creative Commons: Attribution (CC-BY)

https://onlinelibrary.wiley.com/doi/full/10.1111/pai.14129Licence: Creative Commons: Attribution (CC-BY)

Cite this

@article{b2c50678bc244b3ea4d633322c55f177,

title = "Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO",

abstract = "Monitoring is a major component of asthma management in children. Regular monitoring allows for diagnosis confirmation, treatment optimization, and natural history review. Numerous factors that may affect disease activity and patient well-being need to be monitored: response and adherence to treatment, disease control, disease progression, comorbidities, quality of life, medication side-effects, allergen and irritant exposures, diet and more. However, the prioritization of such factors and the selection of relevant assessment tools is an unmet need. Furthermore, rapidly developing technologies promise new opportunities for closer, or even {"}real-time,{"} monitoring between visits. Following an approach that included needs assessment, evidence appraisal, and Delphi consensus, the PeARL Think Tank, in collaboration with major international professional and patient organizations, has developed a set of 24 recommendations on pediatric asthma monitoring, to support healthcare professionals in decision-making and care pathway design.",

keywords = "Humans, Asthma/diagnosis, Child, Quality of Life, Anti-Asthmatic Agents/therapeutic use, Delphi Technique, Monitoring, Physiologic/methods",

author = "{WAO Pediatric Asthma Committee} and Papadopoulos, {Nikolaos G} and Adnan Custovic and Antoine Deschildre and Gern, {James E} and {Nieto Garcia}, Antonio and Michael Miligkos and Wanda Phipatanakul and Gary Wong and Paraskevi Xepapadaki and Ioana Agache and Stefania Arasi and {Awad El-Sayed}, Zeinab and Bacharier, {Leonard B} and Matteo Bonini and Fulvio Braido and Davide Caimmi and Castro-Rodriguez, {Jose A} and Zhimin Chen and Michael Clausen and Timothy Craig and Zuzana Diamant and Ducharme, {Francine M} and Motohiro Ebisawa and Philippe Eigenmann and Wojciech Feleszko and Vincezo Fierro and Alessandro Fiocchi and Luis Garcia-Marcos and Anne Goh and G{\'o}mez, {Ren{\'e} Maximiliano} and Maia Gotua and Eckard Hamelmann and Gunilla Hedlin and Hossny, {Elham M} and Zhanat Ispayeva and Jackson, {Daniel J} and Tuomas Jartti and Milo{\v s} Jese{\v n}{\'a}k and Omer Kalayci and Alan Kaplan and Konradsen, {Jon R} and Piotr Kuna and Susanne Lau and {Le Souef}, Peter and Lemanske, {Robert F} and Michael Levin and Makela, {Mika J} and Mathioudakis, {Alexander G} and Oleksandr Mazulov and M{\'a}rio Morais-Almeida and Clare Murray and Karthik Nagaraju and Zoltan Novak and Ruby Pawankar and Pijnenburg, {Marielle W} and Helena Pite and Pitrez, {Paulo M} and Petr Pohunek and David Price and Alfred Priftanji and Valeria Ramiconi and {Rivero Yeverino}, Daniela and Graham Roberts and Aziz Sheikh and Kun-Ling Shen and Zsolt Szepfalusi and Ioanna Tsiligianni and Mirjana Turkalj and Steve Turner and Tetiana Umanets and Arunas Valiulis and Susanne Vijveberg and Jiu-Yao Wang and Tonya Winders and Yon, {Dong Keon} and Yusuf, {Osman M} and Zar, {Heather J}",

note = "{\textcopyright} 2024 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.",

year = "2024",

month = apr,

day = "25",

doi = "10.1111/pai.14129",

language = "English",

volume = "35",

journal = "Pediatric Allergy and Immunology",

issn = "0905-6157",

publisher = "Blackwell Munksgaard",

number = "4",

}

TY - JOUR

T1 - Recommendations for asthma monitoring in children

T2 - A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO

AU - WAO Pediatric Asthma Committee

AU - Papadopoulos, Nikolaos G

AU - Custovic, Adnan

AU - Deschildre, Antoine

AU - Gern, James E

AU - Nieto Garcia, Antonio

AU - Miligkos, Michael

AU - Phipatanakul, Wanda

AU - Wong, Gary

AU - Xepapadaki, Paraskevi

AU - Agache, Ioana

AU - Arasi, Stefania

AU - Awad El-Sayed, Zeinab

AU - Bacharier, Leonard B

AU - Bonini, Matteo

AU - Braido, Fulvio

AU - Caimmi, Davide

AU - Castro-Rodriguez, Jose A

AU - Chen, Zhimin

AU - Clausen, Michael

AU - Craig, Timothy

AU - Diamant, Zuzana

AU - Ducharme, Francine M

AU - Ebisawa, Motohiro

AU - Eigenmann, Philippe

AU - Feleszko, Wojciech

AU - Fierro, Vincezo

AU - Fiocchi, Alessandro

AU - Garcia-Marcos, Luis

AU - Goh, Anne

AU - Gómez, René Maximiliano

AU - Gotua, Maia

AU - Hamelmann, Eckard

AU - Hedlin, Gunilla

AU - Hossny, Elham M

AU - Ispayeva, Zhanat

AU - Jackson, Daniel J

AU - Jartti, Tuomas

AU - Jeseňák, Miloš

AU - Kalayci, Omer

AU - Kaplan, Alan

AU - Konradsen, Jon R

AU - Kuna, Piotr

AU - Lau, Susanne

AU - Le Souef, Peter

AU - Lemanske, Robert F

AU - Levin, Michael

AU - Makela, Mika J

AU - Mathioudakis, Alexander G

AU - Mazulov, Oleksandr

AU - Morais-Almeida, Mário

AU - Murray, Clare

AU - Nagaraju, Karthik

AU - Novak, Zoltan

AU - Pawankar, Ruby

AU - Pijnenburg, Marielle W

AU - Pite, Helena

AU - Pitrez, Paulo M

AU - Pohunek, Petr

AU - Price, David

AU - Priftanji, Alfred

AU - Ramiconi, Valeria

AU - Rivero Yeverino, Daniela

AU - Roberts, Graham

AU - Sheikh, Aziz

AU - Shen, Kun-Ling

AU - Szepfalusi, Zsolt

AU - Tsiligianni, Ioanna

AU - Turkalj, Mirjana

AU - Turner, Steve

AU - Umanets, Tetiana

AU - Valiulis, Arunas

AU - Vijveberg, Susanne

AU - Wang, Jiu-Yao

AU - Winders, Tonya

AU - Yon, Dong Keon

AU - Yusuf, Osman M

AU - Zar, Heather J

PY - 2024/4/25

Y1 - 2024/4/25

N2 - Monitoring is a major component of asthma management in children. Regular monitoring allows for diagnosis confirmation, treatment optimization, and natural history review. Numerous factors that may affect disease activity and patient well-being need to be monitored: response and adherence to treatment, disease control, disease progression, comorbidities, quality of life, medication side-effects, allergen and irritant exposures, diet and more. However, the prioritization of such factors and the selection of relevant assessment tools is an unmet need. Furthermore, rapidly developing technologies promise new opportunities for closer, or even "real-time," monitoring between visits. Following an approach that included needs assessment, evidence appraisal, and Delphi consensus, the PeARL Think Tank, in collaboration with major international professional and patient organizations, has developed a set of 24 recommendations on pediatric asthma monitoring, to support healthcare professionals in decision-making and care pathway design.

AB - Monitoring is a major component of asthma management in children. Regular monitoring allows for diagnosis confirmation, treatment optimization, and natural history review. Numerous factors that may affect disease activity and patient well-being need to be monitored: response and adherence to treatment, disease control, disease progression, comorbidities, quality of life, medication side-effects, allergen and irritant exposures, diet and more. However, the prioritization of such factors and the selection of relevant assessment tools is an unmet need. Furthermore, rapidly developing technologies promise new opportunities for closer, or even "real-time," monitoring between visits. Following an approach that included needs assessment, evidence appraisal, and Delphi consensus, the PeARL Think Tank, in collaboration with major international professional and patient organizations, has developed a set of 24 recommendations on pediatric asthma monitoring, to support healthcare professionals in decision-making and care pathway design.

KW - Humans

KW - Asthma/diagnosis

KW - Child

KW - Quality of Life

KW - Anti-Asthmatic Agents/therapeutic use

KW - Delphi Technique

KW - Monitoring, Physiologic/methods

U2 - 10.1111/pai.14129

DO - 10.1111/pai.14129

M3 - Review article

C2 - 38664926

SN - 0905-6157

VL - 35

JO - Pediatric Allergy and Immunology

JF - Pediatric Allergy and Immunology

IS - 4

M1 - e14129

ER -

Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO

Abstract

Keywords / Materials (for Non-textual outputs)

Access to Document

Fingerprint

Cite this